| Prime Regenerative And Pain Management | |
|
402 Chatham Square Office Park, Fredericksburg, VA 22405-2544 | |
| (540) 659-5414 | |
| (406) 595-4155 |
| Full Name | Prime Regenerative And Pain Management |
|---|---|
| Type | Facility |
| Speciality | Physical Medicine & Rehabilitation - Pain Medicine |
| Location | 402 Chatham Square Office Park, Fredericksburg, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205394855 | NPI | - | NPPES |
| 0101243180 | Other | VA | LICENCE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | (* (Not Available)) | Secondary |
| 2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | (* (Not Available)) | Primary |
| Provider Name | Devashish Sen |
|---|---|
| Provider Type | Practitioner - Interventional Pain Management |
| Provider Identifiers | NPI Number: 1710959986 PECOS PAC ID: 7911986088 Enrollment ID: I20080521000572 |
News Archive
A benign crystal protein, produced naturally by bacteria and used as an organic pesticide, could be a safe, inexpensive treatment for parasitic worms in humans and provide effective relief to over a billion people around the world.
Carlos E. Prada, MD of Cincinnati Children's Hospital and James D. Weisfeld-Adams, MD of Mount Sinai School of Medicine, NY were honored as the 2012-2013 recipients of the Genzyme/ACMG Foundation Medical Genetics Training Award in Clinical Biochemical Genetics at the ACMG 2012 Annual Clinical Genetics Meeting in Charlotte, NC.
The evidence emerging from the EC funded EARNEST Project is beginning to shine some light into intriguing and potentially difficult ethical questions concerning the impact that nutrition in the womb and in early life has on our healthy life chances.
FDA approves Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia associated with Parkinson's disease.
› Verified 4 days ago
| Provider Name | Apryl Young |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144713926 PECOS PAC ID: 6103159595 Enrollment ID: I20190618002055 |
News Archive
A benign crystal protein, produced naturally by bacteria and used as an organic pesticide, could be a safe, inexpensive treatment for parasitic worms in humans and provide effective relief to over a billion people around the world.
Carlos E. Prada, MD of Cincinnati Children's Hospital and James D. Weisfeld-Adams, MD of Mount Sinai School of Medicine, NY were honored as the 2012-2013 recipients of the Genzyme/ACMG Foundation Medical Genetics Training Award in Clinical Biochemical Genetics at the ACMG 2012 Annual Clinical Genetics Meeting in Charlotte, NC.
The evidence emerging from the EC funded EARNEST Project is beginning to shine some light into intriguing and potentially difficult ethical questions concerning the impact that nutrition in the womb and in early life has on our healthy life chances.
FDA approves Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia associated with Parkinson's disease.
› Verified 4 days ago
| Provider Name | Tran Le Khuu |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851421556 PECOS PAC ID: 3274680327 Enrollment ID: I20200427001311 |
News Archive
A benign crystal protein, produced naturally by bacteria and used as an organic pesticide, could be a safe, inexpensive treatment for parasitic worms in humans and provide effective relief to over a billion people around the world.
Carlos E. Prada, MD of Cincinnati Children's Hospital and James D. Weisfeld-Adams, MD of Mount Sinai School of Medicine, NY were honored as the 2012-2013 recipients of the Genzyme/ACMG Foundation Medical Genetics Training Award in Clinical Biochemical Genetics at the ACMG 2012 Annual Clinical Genetics Meeting in Charlotte, NC.
The evidence emerging from the EC funded EARNEST Project is beginning to shine some light into intriguing and potentially difficult ethical questions concerning the impact that nutrition in the womb and in early life has on our healthy life chances.
FDA approves Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia associated with Parkinson's disease.
› Verified 4 days ago
| Provider Name | Erin Duggins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1114646601 PECOS PAC ID: 8123495892 Enrollment ID: I20221109001669 |
News Archive
A benign crystal protein, produced naturally by bacteria and used as an organic pesticide, could be a safe, inexpensive treatment for parasitic worms in humans and provide effective relief to over a billion people around the world.
Carlos E. Prada, MD of Cincinnati Children's Hospital and James D. Weisfeld-Adams, MD of Mount Sinai School of Medicine, NY were honored as the 2012-2013 recipients of the Genzyme/ACMG Foundation Medical Genetics Training Award in Clinical Biochemical Genetics at the ACMG 2012 Annual Clinical Genetics Meeting in Charlotte, NC.
The evidence emerging from the EC funded EARNEST Project is beginning to shine some light into intriguing and potentially difficult ethical questions concerning the impact that nutrition in the womb and in early life has on our healthy life chances.
FDA approves Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia associated with Parkinson's disease.
› Verified 4 days ago
| Provider Name | Tran Le Khuu |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1851421556 PECOS PAC ID: 3274680327 Enrollment ID: I20230601002131 |
News Archive
A benign crystal protein, produced naturally by bacteria and used as an organic pesticide, could be a safe, inexpensive treatment for parasitic worms in humans and provide effective relief to over a billion people around the world.
Carlos E. Prada, MD of Cincinnati Children's Hospital and James D. Weisfeld-Adams, MD of Mount Sinai School of Medicine, NY were honored as the 2012-2013 recipients of the Genzyme/ACMG Foundation Medical Genetics Training Award in Clinical Biochemical Genetics at the ACMG 2012 Annual Clinical Genetics Meeting in Charlotte, NC.
The evidence emerging from the EC funded EARNEST Project is beginning to shine some light into intriguing and potentially difficult ethical questions concerning the impact that nutrition in the womb and in early life has on our healthy life chances.
FDA approves Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia associated with Parkinson's disease.
› Verified 4 days ago
| Provider Name | Saba Tassaw |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1316631922 PECOS PAC ID: 6800244716 Enrollment ID: I20231201001939 |
News Archive
A benign crystal protein, produced naturally by bacteria and used as an organic pesticide, could be a safe, inexpensive treatment for parasitic worms in humans and provide effective relief to over a billion people around the world.
Carlos E. Prada, MD of Cincinnati Children's Hospital and James D. Weisfeld-Adams, MD of Mount Sinai School of Medicine, NY were honored as the 2012-2013 recipients of the Genzyme/ACMG Foundation Medical Genetics Training Award in Clinical Biochemical Genetics at the ACMG 2012 Annual Clinical Genetics Meeting in Charlotte, NC.
The evidence emerging from the EC funded EARNEST Project is beginning to shine some light into intriguing and potentially difficult ethical questions concerning the impact that nutrition in the womb and in early life has on our healthy life chances.
FDA approves Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia associated with Parkinson's disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Prime Regenerative And Pain Management 402 Chatham Square Office Park, Fredericksburg, VA 22405-2544 Ph: (540) 659-5414 | Prime Regenerative And Pain Management 402 Chatham Square Office Park, Fredericksburg, VA 22405-2544 Ph: (540) 659-5414 |
News Archive
A benign crystal protein, produced naturally by bacteria and used as an organic pesticide, could be a safe, inexpensive treatment for parasitic worms in humans and provide effective relief to over a billion people around the world.
Carlos E. Prada, MD of Cincinnati Children's Hospital and James D. Weisfeld-Adams, MD of Mount Sinai School of Medicine, NY were honored as the 2012-2013 recipients of the Genzyme/ACMG Foundation Medical Genetics Training Award in Clinical Biochemical Genetics at the ACMG 2012 Annual Clinical Genetics Meeting in Charlotte, NC.
The evidence emerging from the EC funded EARNEST Project is beginning to shine some light into intriguing and potentially difficult ethical questions concerning the impact that nutrition in the womb and in early life has on our healthy life chances.
FDA approves Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia associated with Parkinson's disease.
› Verified 4 days ago